Literature DB >> 8219777

Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis.

I Terao1, S Hashimoto, T Horie.   

Abstract

Sarcoidosis is a systemic granulomatous disorder of unknown origin characterized by activated T-lymphocytes and macrophages. Macrophage/monocyte-derived cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) have been shown to be involved in the pathogenesis of sarcoidosis. Although the production of TNF-alpha and IL-1 by alveolar macrophages (AM) and peripheral monocytes (PM) in response to lipopolysaccharide (LPS) in sarcoidosis has been well demonstrated, the production of these cytokines in response to granulocyte-macrophage colony-stimulating factor (GM-CSF) has not been delineated. The present studies were designed to examine the regulatory effect of GM-CSF on TNF-alpha and IL-1 beta production by AM and PM from patients with pulmonary sarcoidosis. Amounts of TNF-alpha and IL-1 beta in the culture supernatants of unstimulated AM from patients with sarcoidosis were significantly higher than those from normal subjects, whereas, there was no difference in the amounts of TNF-alpha and IL-1 beta in the culture supernatants of PM between patients with sarcoidosis and normal subjects. The amounts of TNF-alpha and IL-1 beta in the culture supernatants of GM-CSF or LPS-stimulated AM and PM were significantly higher than those of similarly stimulated AM and PM from normal subjects. This hyperresponsiveness of AM and PM to GM-CSF in patients with sarcoidosis might be relevant to the pathogenesis of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219777     DOI: 10.1159/000236532

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Granulocyte-macrophage colony-stimulating factor amplification of interleukin-1beta and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms.

Authors:  A A Baqui; T F Meiller; J J Chon; B F Turng; W A Falkler
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

2.  Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells.

Authors:  K Mizuno; H Okamoto; T Horio
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

3.  Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis.

Authors:  S Hashimoto; T Nakayama; Y Gon; N Hata; T Koura; S Maruoka; K Matsumoto; S Hayashi; Y Abe; T Horie
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 4.  Human Lung Mononuclear Phagocytes in Health and Disease.

Authors:  Faezzah Baharom; Gregory Rankin; Anders Blomberg; Anna Smed-Sörensen
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

Review 5.  Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.

Authors:  Sarah A Greaves; Shaikh M Atif; Andrew P Fontenot
Journal:  Front Immunol       Date:  2020-03-18       Impact factor: 7.561

Review 6.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.